ASX ANNOUNCEMENT Brisbane, 1st May, 2017 ADMEDUS HSV-2 PHASE IIa RESULTS WEBINAR • Admedus investor webinar Thursday, 4 May 2017 • 9am AEST Sydney/Melbourne/Brisbane time; 7am AWST Perth time Admedus Limited (ASX:AHZ) today announced that it will hold an investor webinar on Thursday, 4 May 2017 to present the results of the HSV-2 Phase IIa program and provide a business overview on the rest of its immunotherapies programs including the HPV treatment program and its work in the area of RNA vaccines. The webinar details Date: 4 May, 2017 Time: 9am Australian Eastern Standard Time (AEST); 7am Australian Western Standard Time (ASWT) Please register to attend the webinar at: https://attendee.gotowebinar.com/register/2780413500734718467 Follow us: Twitter: @Admedus Facebook: www.facebook.com/pages/Admedus Website: www.admedus.com
- Forums
- ASX - By Stock
- AVR
- Ann: HSV-2 Phase IIa Results Investor Webinar
Ann: HSV-2 Phase IIa Results Investor Webinar, page-2
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M |
Open | High | Low | Value | Volume |
$11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 156 | $11.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.00 | 6045 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 156 | 11.800 |
1 | 870 | 11.600 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
1 | 1000 | 11.200 |
Price($) | Vol. | No. |
---|---|---|
12.000 | 6045 | 3 |
12.400 | 198 | 1 |
12.500 | 429 | 1 |
12.850 | 1000 | 1 |
13.000 | 4000 | 2 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online